Procedure of risk rducing surgery for hereditary gynecologic tumor

Procedure of risk rducing surgery for hereditary gynecologic tumor - RRSO

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033751

Enrollment

Registered

2018-10-01

Start date

2018-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BRCA1, BRCA2,MLH1,MSH2,MSH6,PMS2,BRIP1,RAD51C or RAD51D mutation carriers

Interventions

Risk reducing salpingo-oophorectomy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: BRCA1, BRCA2,MLH1,MSH2,MSH6,PMS2,BRIP1,RAD51C or RAD51D mutation carrier

Exclusion criteria

Exclusion criteria: Woman affected a gynecology cancer

Design outcomes

Primary

Measure	Time frame
Incidence rate of ovarian, fallopian tubal and peritoneal cancer	—

Countries

Japan

Contacts

Public ContactWatanabe Takafumi

Fukushima Medical University Obstetrics and Gynecology

t-wata@fmu.ac.jp024-547-1290

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026